Indication

Monoclonal B-Cell Lymphocytosis

1 clinical trial

1 product

Clinical trial

Randomized Double-Blind Phase 2 Trial of Ibrutinib Versus Standard Treatment for COVID-19 Illness Requiring Hospitalization With Safety Lead-In

Status: Completed, Estimated PCD: 2022-09-20

Product